Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Sigyn Therapy™
  • Oncology
    • Overview
    • ImmunePrep™
    • ChemoPrep™
    • ChemoPure™
  • News
    • Press Releases
    • Presentations
    • Resources
  • Media
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Email Alerts
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • CEO Notes

Resources

News

News

  • Press Releases
  • Presentations
  • Resources
Sigyn TherapyTM, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections
May 6, 2024

Sigyn TherapyTM, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections

The Prevalence of Inflammation and Endotoxemia in End-Stage Renal Disease (ESRD)
Feb 23, 2023

The Prevalence of Inflammation and Endotoxemia in End-Stage Renal Disease (ESRD)

Sigyn Therapy in Action Video
Feb 17, 2022

Sigyn Therapy in Action Video

RSS
© 2025 Sigyn Therapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap